Compare Humana Inc (HUM) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Shell PLC — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Shell PLC trades at $90.53 (market cap $245.77B). The key difference: Shell PLC is far larger — about 5.3× Humana Inc's market cap, and Shell PLC pays the higher dividend (3.47%). Which is the better fit depends on your goals.
| HUM | SHEL | |
|---|---|---|
Market Cap | $46.31B | $245.77B |
Sector | Health | Energy |
52-Week High | $409.42 | $94.15 |
52-Week Low | $163.67 | $70.31 |
Enterprise Value | $53.67B | $287.47B |
Dividend Yield | 0.92% | 3.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Shell (SHEL) trades at $88.50, down 1.23% today, with a bullish technical signal from moving averages and neutral oscillators. Recent earnings beat expectations in Q1 and Q2 2026, driven by higher oil prices and operational gains. The company maintains strong cash flow, reduced debt, and a discounted valuation with a P/E of 9.79. Analysts show strong buy sentiment, with a consensus price target of $103.60, and recent news highlights strategic asset sales and investments in gas projects.
Outlook is positive with earnings momentum and shareholder returns via dividends and buybacks, but risks include oil price volatility and regulatory pressures. The stock offers value with upside potential, though investors should monitor commodity swings and geopolitical factors affecting energy markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
